| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/03/2002 | US20020002161 5-HT ligands used to treat central nervous system disorders |
| 01/03/2002 | US20020002155 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 01/03/2002 | US20020002145 Adenosine A2A receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 01/03/2002 | US20020002141 For inhibiting apoptosis or apoptosis-like cell death |
| 01/03/2002 | US20020001597 Eliciting in vertebrate a protective immune response against bacterium of the genus Chlamydia; carrier group coupled to oligosaccharide |
| 01/03/2002 | US20020001576 Medicaments containing allogenic activated-CD4+ cells as the main ingradient, which are attributable to an organ or bone marrow implant donor, have extreemly beneficial effect for preventing tumor and various infections |
| 01/03/2002 | DE10028204A1 Verfahren zur Auffindung von medizinisch wertvollen Wirkstoffen Method for identifying medically valuable active ingredients |
| 01/03/2002 | CA2783274A1 Vaccine composition |
| 01/03/2002 | CA2415238A1 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
| 01/03/2002 | CA2414401A1 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/03/2002 | CA2414150A1 Modified forms of nonsteroidal anti-inflammatory drugs and uses thereof |
| 01/03/2002 | CA2413800A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 01/03/2002 | CA2413683A1 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | CA2413673A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2002 | CA2413547A1 B7-like molecules and uses thereof |
| 01/03/2002 | CA2413301A1 Methods for using tetanus toxin for benificial purposes in animals (mammals) |
| 01/03/2002 | CA2412701A1 Methods for producing modified glycoproteins |
| 01/03/2002 | CA2412635A1 Novel proteases |
| 01/03/2002 | CA2412610A1 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2381338A1 Human lyases |
| 01/02/2002 | EP1167526A1 IgE-dependent histamine-releasing factor(HRF)receptor, HRF-binding peptides and nucleic acids encoding the same, and uses thereof |
| 01/02/2002 | EP1167379A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167378A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167377A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167374A1 Glycosphingolipid |
| 01/02/2002 | EP1167366A1 Amine derivatives |
| 01/02/2002 | EP1167363A2 Novel crystalline forms of (3S-trans)-2-(3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl)-4-(trifluoromethyl)-benzoic acid |
| 01/02/2002 | EP1167360A1 Human chymase inhibitors |
| 01/02/2002 | EP1166801A1 Preparations containing silicon dioxide to improve the taste thereof |
| 01/02/2002 | EP1166786A1 Medicinal compositions |
| 01/02/2002 | EP1166778A2 The use of growth hormone scretagogues to treat systemic lupus erythematosus and inflammatory bowel disease |
| 01/02/2002 | EP1165827A1 45 human secreted proteins |
| 01/02/2002 | EP1165805A1 Dsp-2 dual-specificity map kinase phosphatase |
| 01/02/2002 | EP1165789A2 Vesicle associated proteins |
| 01/02/2002 | EP1165788A2 Molecules of the immune system |
| 01/02/2002 | EP1165784A2 Nucleic acids including open reading frames encoding polypeptides; "orfx" |
| 01/02/2002 | EP1165781A2 Protease resistant flint analogs |
| 01/02/2002 | EP1165778A2 Casb618 polynucleotides and polypeptides and their use |
| 01/02/2002 | EP1165615A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 01/02/2002 | EP1165606A1 50 human secreted proteins |
| 01/02/2002 | EP1165602A1 49 human secreted proteins |
| 01/02/2002 | EP1165598A1 Hookworm platelet inhibitor |
| 01/02/2002 | EP1165594A1 Antisense oligonucleotide modulation of stat3 expression |
| 01/02/2002 | EP1165593A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
| 01/02/2002 | EP1165575A1 Phosphate containing macrocyclic immunomodulators |
| 01/02/2002 | EP1165567A2 Sulfamate containing macrocyclic immunomodulators |
| 01/02/2002 | EP1165566A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 01/02/2002 | EP1165562A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/02/2002 | EP1165561A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents |
| 01/02/2002 | EP1165555A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 01/02/2002 | EP1165545A1 Novel compounds |
| 01/02/2002 | EP1165544A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
| 01/02/2002 | EP1165533A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/02/2002 | EP1165528A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 01/02/2002 | EP1165513A1 Indolinone compounds as kinase inhibitors |
| 01/02/2002 | EP1165506A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP1165490A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 01/02/2002 | EP1165185A2 Human tumor necrosis factor receptor-like 2 |
| 01/02/2002 | EP1165143A2 Method for expressing proteins |
| 01/02/2002 | EP1165132A2 Dry formulation for transcutaneous immunization |
| 01/02/2002 | EP1165125A2 Antigen-specific induction of peripheral immune tolerance |
| 01/02/2002 | EP1165122A2 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy |
| 01/02/2002 | EP1165112A1 Modulators of polysaccharides and uses thereof |
| 01/02/2002 | EP1165101A2 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) |
| 01/02/2002 | EP1165092A1 Cyclopentanone derivatives and their use |
| 01/02/2002 | EP1165085A1 Phthalazine derivatives for treating inflammatory diseases |
| 01/02/2002 | EP1165072A2 Valdecoxib compositions |
| 01/02/2002 | EP1164874A1 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and the use thereof for reducing transport through tight junctions |
| 01/02/2002 | EP1135151A4 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 01/02/2002 | EP1109789A4 Triptolide prodrugs having high aqueous solubility |
| 01/02/2002 | EP1005372B1 Anti-cd40l immunotoxins for the treatment of diseases |
| 01/02/2002 | EP0745074B1 4-amino derivatives of mycophenolic acid with immunosuppressant activity |
| 01/02/2002 | EP0722457B1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 01/02/2002 | CN1329668A Polyketide synthase enzymes and recombinant DNA constructs therefor |
| 01/02/2002 | CN1329601A New benzimidazolone-benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 01/02/2002 | CN1329597A Pyridinium derivatives for treatment of diabetic and aging-related vascular complications |
| 01/02/2002 | CN1329507A Topical compositions comprising ascomycins |
| 01/02/2002 | CN1329506A Formulation with an improved therapeutic range, cntainng nucleotide synthesis inhibitors |
| 01/02/2002 | CN1329505A Composition and method for treating allergic diseases |
| 01/02/2002 | CN1329490A Composition and method for treating allergic diseases |
| 01/02/2002 | CN1329465A Baby food stimulating growth of the thymus |
| 01/02/2002 | CN1329166A A novel polypeptide-human non-integral protein-metalloprotease 11.11 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329092A A novel polypeptide-human RS3 protien 18 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329045A A novel polypeptide-mouse zinc finger protein (Zfp-1) protein 16 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329043A A novel polypeptide-human L1 factor ORF2 inversed transcriptive related protein 15 and plynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329042A A novel polypeptide-human zinc finger protein FPM 315-17 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329040A A novel polypeptide-human L1 factor ORF2 inversed transcriptive related protein 13 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329031A A novel polypeptide-human RNA conjugated protein 19 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329027A A novel polypeptide-human lymph enhancer 42 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329024A A novel polypeptide-activating GTP enzyme protein negative regulatory factor 11.66 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329018A A novel polypeptide-phytochrome 9.9 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1329008A A novel polypeptide-H1yD protein family secretory protein 11 and polynucleotide for coding this polypeptide |
| 01/02/2002 | CN1077103C Chiral methyl phenyl oxazolidinones |
| 01/01/2002 | US6335459 Prostaglandin i2 receptor modulators; treating tissue necrosis, premature uterine contraction, gastric ulceration, sexual dysfunction, menstrual pain and improper wound healing, immunoregulation, platelet aggregation or neutrophil function |
| 01/01/2002 | US6335427 Component of stem bromelain |